Sequoia Capital China and HighLight Capital have led a RMB550 million ($80 million) pre-IPO funding round for BrightGene Bio-Medical Technology, a Chinese developer of innovative and generic drugs. An investment unit of GF Securities also participated.
The company was established in 2001 and received funding from Lilly Asia Ventures in 2010. AVCJ Research’s records indicate that Suzhou International Development Venture Capital invested the same year,...
Shenzhen Scholar Education, a Chinese after-school tutoring business backed by CRE Alliance, has filed for an IPO in Hong Kong.
Bryan Lewis, CIO of Pennsylvania State Employees’ Retirement System, discusses accessing Asia, approaches to co-investment, and paring a bloated PE portfolio into a smaller set of strategic relationships
ChrysCapital Partners has increased its fund size and its commitment to operations in response to a maturation of the Indian market characterized by bigger deals and more opportunities to drive change
Apax Partners has agreed to pay $200 million for a significant minority stake in India and US-based data analytics provider Fractal Analytics.